XML 30 R8.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Jul. 31, 2024
Jul. 31, 2023
Jul. 31, 2022
Cash flows from operating activities:      
Net loss $ (99,985,000) $ (26,899,000) $ (33,052,000)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:      
Depreciation and amortization of property, plant and equipment 12,159,000 11,922,000 10,314,000
Amortization of intangible assets with finite lives 21,154,000 21,396,000 21,396,000
Amortization of stock-based compensation 6,096,000 10,107,000 7,767,000
Amortization of deferred financing costs 3,985,000 1,852,000 811,000
Amortization of cost to fulfill assets 960,000 959,000 469,000
Write-off of deferred financing costs 1,832,000 0 0
CEO transition costs related to equity-classified stock-based awards 0 3,764,000 7,388,000
Change in fair value of warrants and derivatives (4,273,000) 0 0
Change in fair value of convertible preferred stock purchase option liability 0 0 1,005,000
Paid-in-kind interest under Term Loan 337,000 0 0
Loss on business divestiture 1,199,000 0 0
Changes in other liabilities (4,110,000) (4,133,000) (4,132,000)
Loss (gain) on disposal of property, plant and equipment 889,000 48,000 (310,000)
Provision for allowance for doubtful accounts 1,422,000 261,000 838,000
Provision for excess and obsolete inventory 2,801,000 4,871,000 4,447,000
Deferred income tax benefit (2,990,000) (6,060,000) (5,856,000)
Impairment of long-lived assets, including goodwill 64,525,000 0 0
Changes in assets and liabilities, net of effects of divestitures:      
Accounts receivable (38,305,000) (39,709,000) 33,567,000
Inventories (7,763,000) (14,885,000) (20,406,000)
Prepaid expenses and other current assets 4,282,000 1,656,000 (3,190,000)
Other assets (717,000) (3,356,000) (6,656,000)
Accounts payable (18,930,000) 20,362,000 6,833,000
Accrued expenses and other current liabilities 755,000 671,000 (11,081,000)
Contract liabilities 2,755,000 10,194,000 (1,362,000)
Other liabilities, non-current 14,000 (324,000) (3,690,000)
Interest payable (296,000) 1,197,000 (22,000)
Income taxes payable (2,291,000) 1,673,000 (1,071,000)
Net cash (used in) provided by operating activities (54,495,000) (4,433,000) 1,997,000
Cash flows from investing activities:      
Purchases of property, plant and equipment (13,083,000) (18,311,000) (19,619,000)
Net cash provided by (used in) investing activities 20,142,000 (18,311,000) (19,619,000)
Cash flows from financing activities:      
Net (payments) borrowings under revolving loans (85,300,000) 36,900,000 (71,000,000)
Proceeds from term loan facilities 157,140,000 0 0
Proceeds from issuance of convertible preferred stock 43,200,000 0 100,000,000
Proceeds from issuance of employee stock purchase plan shares 254,000 470,000 734,000
Repayment of term loan facilities 48,800,000 1,875,000 0
Payment of deferred financing costs (10,294,000) (3,809,000) (140,000)
Remittance of employees' statutory tax withholding for stock awards (3,815,000) (2,869,000) (6,109,000)
Cash dividends paid on common stock (268,000) (8,661,000) (11,048,000)
Repayment of principal amounts under finance lease and other obligations 0 (4,000) (15,000)
Net cash provided by financing activities 47,825,000 20,051,000 8,415,000
Net increase (decrease) in cash and cash equivalents 13,472,000 (2,693,000) (9,207,000)
Cash and cash equivalents at beginning of year 18,961,000 21,654,000 30,861,000
Cash and cash equivalents at end of year 32,433,000 18,961,000 21,654,000
Supplemental cash flow disclosure      
Interest 18,097,000 11,914,000 4,094,000
Income taxes, net 4,877,000 361,000 2,913,000
Non-cash investing and financing activities:      
Adjustment to reflect redemption value of convertible preferred stock 15,900,000 7,007,000 10,216,000
Accrued deferred financing costs 1,114,000 0 0
Accrued additions to property, plant and equipment 961,000 993,000 5,586,000
Accrued remittance of employees' statutory tax withholdings for fully-vested share units 424,000 1,204,000 1,102,000
Accrued shelf registration costs 170,000 0 0
Unpaid convertible preferred stock issuance costs 77,000 0 0
Cash dividends declared on common stock but unpaid, including (reversal) accrual of dividend equivalents (107,000) 315,000 3,135,000
Issuance of restricted stock 0 9,000 13,000
Common stock issued for acquisitions 0 0 9,000,000
Establishment of initial convertible preferred stock purchase option liability 0 0 1,005,000
Shelf Registration      
Cash flows from financing activities:      
Payment of issuance cost (20,000) (101,000) 0
Convertible Preferred Stock      
Cash flows from financing activities:      
Payment of issuance cost (4,272,000) 0 (4,007,000)
CGC      
Cash flows from investing activities:      
Proceeds from business divestiture, net $ 33,225,000 $ 0 $ 0